Trials / Conditions / Myocardial Perfusion Imaging

Myocardial Perfusion Imaging

12 registered clinical trials studyying Myocardial Perfusion Imaging — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Terminated	Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis NCT07187895	Sinotau Pharmaceutical Group	Phase 2
Completed	The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography NCT04465526	National Institute of Cardiology, Warsaw, Poland	—
Completed	Dotarem Evaluation for Myocardial Perfusion CMR NCT03937921	Medical University of South Carolina	—
Enrolling By Invitation	Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women NCT04599192	Yale University	—
Completed	Real-Time Myocardial Perfusion Echocardiography in the ICU NCT03173716	Mayo Clinic	Phase 4
Unknown	Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging NCT03150342	Far Eastern Memorial Hospital	—
Completed	Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT NCT03084562	Hospices Civils de Lyon	—
Completed	Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study) NCT03917199	National Institute of Cardiology, Warsaw, Poland	—
Completed	Meta-Analysis of Stress Myocardial Perfusion Imaging NCT03180060	American British Cowdray Medical Center	—
Completed	Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging NCT01221272	Gilead Sciences	Phase 4
Completed	Myocardial Perfusion Imaging in Liver Transplantation Candidates NCT03864497	University Hospital Birmingham NHS Foundation Trust	—
Completed	Myocardial Perfusion MRI NCT01490294	Bayer	Phase 2